Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997

Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997–2007

Published:2011-10 Issue:5 Volume:44 Page:358-363
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Liang-Yu Chen,Kuo Shu-Chen,Liu Chun-Yu,Luo Bin-Syun,Huang Ling-Ju,Lee Yi-Tzu,Chen Chien-Pei,Chen Te-Li,Fung Chang-Phone

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference23 articles.

1. Acinetobacter baumannii: emergence of a successful pathogen;Peleg;Clin Microbiol Rev,2008

2. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii;Dijkshoorn;Nat Rev Microbiol,2007

3. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections;Karageorgopoulos;Lancet Infect Dis,2008

4. Global challenge of multidrug-resistant Acinetobacter baumannii;Perez;Antimicrob Agents Chemother,2007

5. Acinetobacter infection;Munoz-Price;N Engl J Med,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation and characterization of bacteriophages with activities against multi-drug-resistant Acinetobacter nosocomialis causing bloodstream infection in vivo;Journal of Microbiology, Immunology and Infection;2023-10

2. The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment;Journal of Microbiology, Immunology and Infection;2021-04

3. A multicenter study on clinical characteristics of Acinetobacter bacteremia in patients with liver cirrhosis;Journal of Microbiology, Immunology and Infection;2019-12

4. Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy;Antimicrobial Agents and Chemotherapy;2017-09

5. Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia;PLOS ONE;2016-09-19